SCHEMBL6439072

SCHEMBL6439072

CC1=C(C)C(C)C([Si](C)(C)NC(=O)c2ccccc2)=C1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.40
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PAX3 P23760 1/20 0.37
FOXO1 Q12778 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
POLB P06746 2/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
HDAC3 O15379 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
IDO1 P14902 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8464429 0.99 BCAT2 (0.39) BCAT2NPC1RAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL713800 0.97 BCAT2 (0.38) BCAT2NPC1RAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL7715857 0.83 NPC1 (0.40) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL6453437 0.73 HPGD (0.31) HPGD
SCHEMBL6438664 0.70 MEN1 (0.39) MEN1KMT2ASMN1; SMN2MAPTHPGD
SCHEMBL6438616 0.69
SCHEMBL7938016 0.69 HDAC3 (0.54) BCAT2NPC1RAB9AMEN1KMT2A
SCHEMBL451924 0.69 HDAC3 (0.54) BCAT2NPC1RAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL8722324 0.68 MEN1 (0.37) MEN1KMT2ASMN1; SMN2POLBMAPT
Dibenzoylmethane SCHEMBL28456473 0.67 KMT2A (0.59) NPC1RAB9AMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884857-B1 Olefin polymerization process using supported constrained geometry catalysts THE DOW CHEMICAL COMPANY (US) 2005-04-26 US disclosed
US-6858557-B1 Supported constrained geometry olefin polymerization catalysts THE DOW CHEMICAL COMPANY (US) 2005-02-22 US disclosed
US-6806326-B2 TITANIUM COMPLEXES WITH DELOCALIZED PI-BONDED CYCLOPENTADIENYL MOIETY, AND COCATALYST; FOR EXAMPLE, 1-(TERT-BUTYLAMIDO)-2-(TETRAMETHYLCYCLOPENTADIENYL)-ETHANEDIYL TITANIUM DICHLORIDE AND METHYL ALUMOXANE THE DOW CHEMICAL COMPANY 2004-10-19 US disclosed
US-6686488-B2 USING COORDINATION POLYMERIZATION CATALYSTS THE DOW CHEMICAL COMPANY 2004-02-03 US disclosed
US-6670432-B1 Metal is bound to a delocalized substituted pi-bonded moiety (cyclopentadiene) to induce a constrained geometry about the metal; ethylene-styrene copolymer THE DOW CHEMICAL COMPANY 2003-12-30 US disclosed
US-20030065203-A1 Constrained geometry addition polymerization catalysts WILSON DAVID R (US) 2003-04-03 US disclosed
US-20020128403-A1 Constrained geometry addition polymerization catalysts STEVENS JAMES C (US) 2002-09-12 US disclosed
US-6075077-A ETHYLENE COPOLYMER PREPARED USING A CYCLOPENTADIENE COORDINATION COMPLEX OF GIVEN FORMULA WHERE METAL IS BOUND TO A DELOCALIZED SUBSTITUTED PI-BONDED MOIETY TO INDUCE A CONSTRAINED GEOMETRY ABOUT THE METAL, AND COCATALYST THE DOW CHEMICAL COMPANY (US) 2000-06-13 US disclosed
US-6013819-A AS POLYMERIZATION CATALYSTS FOR PRODUCING ADDITION POLYMERS THE DOW CHEMICAL COMPANY (US) 2000-01-11 US disclosed
US-5703187-A ETHYLENICALLY UNSATURATED ADDITION POLYMERS THE DOW CHEMICAL COMPANY (US) 1997-12-30 US disclosed
EP-0416815-B1 Constrained geometry addition polymerization catalysts, processes for their preparation, precursors therefor, methods of use, and novel polymers formed therewith DOW CHEMICAL CO (US) 1997-08-13 EP disclosed
EP-0774468-A2 Constrained geometry addition polymerization catalysts, processes for their preparation, precursors therefor, methods of use, and novel polymers formed therewith THE DOW CHEMICAL COMPANY (US) 1997-05-21 EP disclosed
EP-0765888-A2 Polymers obtainable with a constrained geometry addition polymerization catalyst and process of making atactic alpha-olefin polymers with such catalysts THE DOW CHEMICAL COMPANY (US) 1997-04-02 EP disclosed
EP-0764654-A2 Constrained geometry addition polymerization catalysts, processes for their preparation, precursors therefor, methods of use, and novel polymers formed therewith THE DOW CHEMICAL COMPANY (US) 1997-03-26 EP disclosed
EP-0764653-A2 Constrained geometry addition polymerization catalysts, processes for their preparation, precursors therefor, methods of use, and novel polymers formed therewith THE DOW CHEMICAL COMPANY (US) 1997-03-26 EP disclosed
EP-0764664-A2 Constrained geometry addition polymerization catalysts, processes for their preparation, precursors therefor, methods of use, and novel polymers formed therewith THE DOW CHEMICAL COMPANY (US) 1997-03-26 EP disclosed
EP-0416815-A2 Constrained geometry addition polymerization catalysts, processes for their preparation, precursors therefor, methods of use, and novel polymers formed therewith THE DOW CHEMICAL COMPANY (US) 1991-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065203-A1 Constrained geometry addition polymerization catalysts CPSF6, CPSF1, PICALM BCAT2 870/4885NPC1 4438/4885RAB9A 4034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.